Integer Holdings Co. (ITGR) Stock Price Up 1.5%
Integer Holdings Co. (NASDAQ:ITGR)’s share price rose 1.5% on Tuesday . The stock traded as high as $24.01 and last traded at $23.88, with a volume of 62,939 shares. The stock had previously closed at $23.52.
ITGR has been the subject of several research analyst reports. TheStreet cut Integer Holdings from a “hold” rating to a “sell” rating in a research report on Friday, July 1st. Zacks Investment Research cut Integer Holdings from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 2nd. Finally, Sterne Agee CRT reissued a “buy” rating on shares of Integer Holdings in a research report on Monday, May 16th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $57.00.
The stock’s market cap is $724.44 million. The stock’s 50-day moving average is $0.00 and its 200 day moving average is $0.00.
Integer Holdings (NASDAQ:ITGR) last released its earnings results on Thursday, July 28th. The company reported $0.56 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.70 by $0.14. During the same period in the previous year, the business posted $0.73 EPS. The business earned $348.38 million during the quarter, compared to analysts’ expectations of $356.72 million. The company’s quarterly revenue was up 99.2% on a year-over-year basis. Equities research analysts anticipate that Integer Holdings Co. will post $2.64 EPS for the current fiscal year.
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.